The link between Hodgkin's Lymphoma and Mono
Teenagers and college-age young people frequently contract mononucleosis, an easily-spread disease brought on by the Epstein Barr virus and characterized chiefly by extreme fatigue and swollen lymph nodes. It can last days, weeks, even months.
It's also common for parents of kids with mononucleosis to hear that there is a strong link between that disease and lymphoma, causing an understandable amount of panic. Fortunately, Dr. Judith Palfrey, writing for US News & World Report recently cleared up this confusion.
Dr. Palfrey writes that scientists see a vague "sort of association" between mono and Hodgkin's lymphoma, and that mono is indeed one risk factor for developing Hodgkin's.
However, the very rare nature of Hodgkin's Lymphoma (she says that of 100,000 people between the ages of 15-24, just 4 may develop Hodgkin's) makes the association extremely slim, and the chances of developing it from mono excessively small.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
